Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Swine flu vaccine trials show strong results

  • Comment

Tests for a swine flu vaccine have shown a ‘strong immune response’ after just one dose, according to scientists.

A total of 100 healthy volunteers took part in the trial of the cell-based drug by researchers at the University of Leicester, who monitored how their immune systems responded.

Results showed 80% had a “strong, potentially protective” response after a single dose, which jumped to more than 90% after a second.

Dr Iain Stephenson, the trial leader said: ‘The results suggest that one vaccine dose may be sufficient to protect against A(H1N1) swine flu, rather than two.

“The aim of the trial was to find out how many doses and what type of vaccine is needed to give protection. These initial results should help to plan vaccination campaigns in the autumn, including doses and timings.”

More than 6,000 adults and children are involved in similar trials around the world.

Plans to vaccinate most of the population against swine flu are expected to begin in October after the drug is licensed, and will be used first on “at risk” groups, such as those with asthma and diabetes.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs